Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
about
Clinical and molecular genetics of psychotic depressionFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentPharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.Pharmacogenetics of antidepressant response.Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response.Positive perception of pharmacogenetic testing for psychotropic medicationsSLC6 transporters: structure, function, regulation, disease association and therapeuticsPolymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatmentRelation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adultsReview and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Genome-wide association studies of antidepressant outcome: a brief review.Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary studyHuman serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.Pharmacogenetics in psychiatry: are we ready for widespread clinical use?Incomplete coverage of candidate genes: a poorly considered bias.Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsPharmacogenomics with antidepressants in the STAR*D study.Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for trainingThe modulatory influence of the functional COMT Val158Met polymorphism on lexical decisions and semantic priming.Pharmacogenetics of antidepressant response: an updateEmerging drugs for major depressive disorder.Pharmacogenetic considerations in the treatment of psychiatric disorders.Gene-environment interaction in major depression and antidepressant treatment response.Pharmacogenetics of mood disorders: what clinicians need to know.Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.Genome-wide association studies in pharmacogenomics of antidepressants.Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants.ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression.Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance.Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.Evidence of involvement of the human Par-4 (PAWR) gene in major depressive disorder.
P2860
Q27004154-F7215C03-681E-40D2-9040-6E89B17E5FC4Q27015830-44C00C66-4ADE-47B2-85CC-9166A8E7D0FFQ31144283-63783A74-C93C-4A83-AA34-90060390CA6EQ33919579-A3BEB0CE-5542-4986-80B1-0A380C1DD3D6Q33981170-624FC3B4-1024-494B-8562-CDF1D5CE0053Q34155796-DD286A85-3A0E-4487-BC82-B7854E2132F4Q34292369-1F0F36C8-4BCC-4E55-9D87-A41996A973BCQ34541288-83E79A4A-E570-4210-8A56-E81FD1EF3794Q34649517-C9E46387-F0E8-478A-8833-0CAB3B18F975Q34661625-35EA9EC1-204E-49F9-B213-EC67F2FEB3A2Q34685706-9D6675A2-B4D5-438F-BFA2-12DA4EC189F6Q34871885-933F5CA3-009E-4927-88C7-7DDEE3660EEFQ35074796-533E3A34-F3E4-43FA-8145-85969CCAC637Q36018468-625A3B49-32EB-49AE-803D-9745A3C84448Q36367301-8B640D08-943E-4C60-9CDC-FBF2DA3781CBQ37076472-FA4729F2-42FD-40EE-B782-36D08B068A52Q37108126-1BCE27F2-6891-4C91-A56D-926392EDA143Q37178537-2ABBBE23-4326-4962-88AF-5A06F6852149Q37205961-CE2AE837-4AB8-4F35-80C4-B2FE8DB7BBC0Q37265724-FB75CF8E-0B90-4857-83C2-B8E06C8631A4Q37332253-3ED5659E-B0F0-49DA-B981-D92C03C0205CQ37464458-65338D95-F971-46AC-994A-E9842F612726Q37564562-1B42EB57-3D03-4630-810A-E48FAC1585DEQ37681573-8FD63A4A-7A36-48F2-AE5F-EC6B028C8F53Q37971344-7CAB2165-3446-48FF-8BCC-E89C549CA210Q38139479-AC18C4CC-B1D7-42CB-8AC9-61221DABDEDEQ38170140-D481E1D7-4CFD-456E-8CC5-E8D4A44D990DQ38444447-E180087F-C376-4FE1-8CF2-869D5C1FCEFCQ38606623-7E3E5CC6-BFB3-4EAD-B895-619DC5E0D8D9Q39021015-EA3B6CD8-3835-48BD-8331-619050F092C2Q45754167-6657D1BA-99A6-49C1-BBAD-FD81757F77B9Q46434375-C32EF807-3FB4-4CC9-86B3-8CF6A43EF2B8Q48315286-9E65BE6E-4DD0-4CB9-A1A3-C197969E064BQ48639392-97647477-9D67-4AE4-AED0-339CB599D411Q48787872-A0D579F6-3519-4BD8-B169-6AA0782CF9F1Q48868283-EC213276-EB07-4CEB-94DA-A34C2F522CE0Q49072045-6F01CBA4-AB49-4A4E-B404-C25BEECCA736
P2860
Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
@en
type
label
Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
@en
prefLabel
Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
@en
P2093
P2860
P356
P1476
Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500477
P577
2007-08-07T00:00:00Z
P5875
P6179
1053695803